Current concepts in tall stature and overgrowth syndromes

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue SUPPL. 2, 2001, Pages 975-984

  Drop, S L S ^a   Greggio, N ^a   Cappa, M ^a   Bernasconi, S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Androgen therapy; Consensus guidelines; Growth hormone; Oestrogen therapy; Overgrowth syndromes; Tall stature

Indexed keywords

ETHINYLESTRADIOL; GROWTH HORMONE; HOMEODOMAIN PROTEIN; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE ESTER;

AGE; ARTICLE; BODY HEIGHT; BONE AGE; CHILD; CHILD GROWTH; CHROMOSOME ANALYSIS; CHROMOSOME DISORDER; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DOSE RESPONSE; ENDOCRINE DISEASE; EPIPHYSIODESIS; EXPERIENCE; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC DISORDER; GROWTH DISORDER; HUMAN; MALE; MATHEMATICAL MODEL; ORTHOPEDIC SURGERY; PATHOGENESIS; PATIENT CARE; PHYSICAL EXAMINATION; PREDICTION; PRENATAL PERIOD; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL DISORDER; SOCIAL PSYCHOLOGY; TALL STATURE;

EID: 0034884542     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem-2001-s210     Document Type: Article

References (60)

1. The Y specific growth gene(s): How does it promote stature?
2. SHOX: Pseudoautosomal homeobox containing gene for short stature and dyschondrosteosis
3. Sex steroid treatment of constitutionally tall stature
4. Growth and pubertal development in elite female rhythmic gymnasts
5. Intellectual and physical performance and morbidity in relation to height in a cohort of 18-year-old Swedish conscripts
6. Intelligence and educational level in adult males at the extremes of stature
7. Childhood leg length and adult mortality: Follow up of the Carnegie (Boyd Orr) Survey of Diet and Health in Pre-war Britain
8. Height and risk of death among men and women: Aetiological implications of association with cardiorespiratory disease and cancer mortality
9. Bone age assessment: A large scale comparison of the Greulich and Pyle, and Tanner and Whitehouse (TW2) methods
10. Estrogen: Consequences and implications of human mutations in synthesis and action
11. FISH-deletion mapping defines a 270-kb short stature critical interval in the pseudoautosomal region PAR1 on human sex chromosomes
12. Skeletal features and growth patterns in 14 patients with haplo-insufficiency of SHOX: Implications for the development of Turner syndrome
13. Short stature homeobox-containing gene duplication on the der(X) chromosome in a female with 45,X/46,X, der(X), gonadal dysgenesis, and tall stature
14. Overgrowth syndromes and genomic imprinting: From mouse to man
15. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: Identification of loss-of-function mutations in the GPC3 gene
16. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay
17. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription
18. Androgen receptor defects: Historical, clinical, and molecular perspectives
19. The contribution of testosterone to skeletal development and maintenance: Lessons from the androgen insensitivity syndrome
20. Pubertal growth in patients with androgen insensitivity: Indirect evidence for the importance of estrogens in pubertal growth of girls
21. A comprehensive and critical assessment of overgrowth and overgrowth syndromes
22. Overgrowth disorders
23. Overgrowth. Hormonal Causes
24. Genetic and dysmorphic syndromes with tall stature
25. Overgrowth. Section III Other hormonal causes
26. Genetic disorders associated with overgrowth
27. Overgrowth. Section V. Syndromes and other disorders associated with overgrowth
28. Overgrowth. Section VI. Genetic syndromes and other disorders associated with overgrowth
29. Acceleration of growth and bone maturation in childhood thyrotoxicosis
30. Marfan syndrome
31. Growing interest in overgrowth
32. Tables for predicting adult height from skeletal age; revised for use with the Greulich-Pyle hand standards
33. Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height
34. Prediction of adult height: Methods and problems
35. The prediction of adult height
36. A computerized image analysis system for estimating Tanner-Whitehouse 2 bone age
37. The use of a computerized method of bone age assessment in clinical practice
38. Computer-aided skeletal age scores in healthy children, girls with Turner syndrome, and in children with constitutionally tall stature
39. Computer-aided estimation of skeletal age and comparison with bone age evaluations by the method of Greulich-Pyle and Tanner-Whitehouse
40. Bone age in 116 untreated patients with Turner's syndrome rated by a computer-assisted method (CASAS)
41. A new model to predict final height in constitutionally tall children
42. Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children
43. Long term sequelae of sex steroid treatment in the management of constitutionally tall stature
44. Treatment of excessive height in girls
45. Die Behandlung des konstitutionellen Hochwuchses bei Mädchen mit psysiologischen Östrogendosen in der Präpubertät. Eine Alternative zur hochdosierten Östrogentherapie
46. The surgical management of tall stature
47. Bilateral epiphysiodesis around the knee as treatment for excessive height in boys
48. Bilateral femoral shortening for unaccepted tallness
49. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
50. Psychological indications for treatment of tall stature in adolescent girls
51. Outcome in tall stature. Final height and psychological aspects in 220 patients with and without treatment
52. High dose testosterone therapy for reduction of final height in constitutionally tall boys: Does it influence testicular function in adulthood?
53. Oral contraceptive use and breast cancer risk: A meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use
54. Oral contraceptives and risk of breast cancer in women aged 20-54 years
55. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
56. Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproduction
57. Abnormal growth: Definition, pathogenesis and practical assessment